Soleno Therapeutics (SLNO) · page 393 of 415
The slide uses highlighted text to emphasize key concerns about Vykat's safety profile and Miller's private skepticism.
Activist deck · expose_contradiction · expose_contradiction · overcrowded density
Slide locked Sign in to view
Slide schematic 6/6
paragraph 3/3 quote 1/1 source-note 1/1 title 1/1
Components 6
paragraph paragraph paragraph testimonial source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.